Results 171 to 180 of about 19,899 (238)

Correction to "YY1-Upregulated MTHFD2 Drives Non-Small Cell Lung Cancer Progression Through the Regulation of Lrrk2". [PDF]

J Biochem Mol Toxicol
europepmc   +1 more source

Regulation between LRRK2 and PP2A signaling in cellular models of Parkinson's disease. [PDF]

Biochem J
Athanasopoulos PS, Memou A, Ho FY, Soliman A, Pots H, Papadopoulou V, von Zweydorf F, Sriraman S, Thouin AM, Vandewynckel L, Sibran W, Chartier-Harlin MC, Nichols RJ, Greggio E, Taymans JM, Gloeckner CJ, Rideout HJ, Kortholt A.   +17 more
europepmc   +1 more source

Shared genetic architecture of smoking dependence and Crohn's disease: A cross-trait analysis of GWAS summary statistics. [PDF]

Tob Induc Dis
Ji A, Xu W, Xiong H, Zhong H, Zeng C.
europepmc   +1 more source

Parkinson's disease genetics across diverse ancestries: an observational genetic study of causal and risk variants with translational implications. [PDF]

Lancet Neurol
Lange LM, Fang ZH, Makarious MB, Kuznetsov N, Atterling Brolin K, Ballard S, Bardien S, Doquenia ML, Heutink P, Houlden H, Iwaki H, Jasaityte S, Jones L, Junker J, Kaiyrzhanov R, Koretsky MJ, Kumar KR, Latin American Research Consortium on the Genetics of Parkinson's Disease (LARGE-PD), Leonard HL, Levine KS, Lim SY, Mencacci NE, Mohamed WMY, Nalls MA, Noyce AJ, Ojha R, Okubadejo NU, Ur Rehman S, Screven L, Shashkin C, Sopromadze S, Stafford EJ, Tan AH, Tan M, Tavadyan Z, Trinh J, Tserensodnom B, Valente EM, Vitale D, Zharkinbekova N, Lohmann K, Bandres-Ciga S, Blauwendraat C, Singleton AB, Morris HR, Klein C, Global Parkinson's Genetics Program (GP2).   +46 more
europepmc   +1 more source

RNA Splicing Dysregulation in Parkinson's Disease. [PDF]

Genes (Basel)
Bruno MG, Menichetti G, Valentino A, Javaid A, Belpinati F, Ruggiero A, Valenti MT, Paolone G, Cavaliere F, Trabetti E, Romanelli MG, Bombieri C.   +11 more
europepmc   +1 more source

Return of genetic results to persons with Parkinson's disease: Blessing or foe? [PDF]

J Parkinsons Dis
Shiner T, Alcalay RN.
europepmc   +1 more source

Constrained peptide mimics of the LRRK2 C-terminal Helix inhibits its kinase activity. [PDF]

Bioorg Chem
Chen T, Alexander KK, Martinez Fiesco JA, Naaldijk Y, Fasiczka R, Brahmia B, de la Cruz AA, LeClair TJ, Steude EG, Zhang P, Hilfiker S, Kennedy EJ.   +11 more
europepmc   +1 more source

Rare Variants May Influence Disease Risk and Clinical Features in Sporadic Late-Onset Chinese Parkinson's Disease Patients. [PDF]

Int J Mol Sci
Ho RW, Xiong Z, Lo RC, Liu H, Ho PW, Sham PC, Ho SL, Pang SY.   +7 more
europepmc   +1 more source

Single-cell RNA profiling of oligodendroglial lineage cells derived from iPSCs carrying Parkinson's disease-relevant LRRK2-G2019S mutation. [PDF]

iScience
Karmali N, Kessler W, Dehestani M, Sun W, Drwesh L, Volos P, Tsitkov S, Dhingra A, Thomas C, Rodriguez-Nieto S, Tietz J, Schafflick D, Fernandes N, Fitzgerald J, Fraenkel E, Gasser T, Rafiq NM, Kuhlmann T, Bansal V.   +18 more
europepmc   +1 more source

Mitochondrial resilience: a convergent framework for pathogenesis and neuroprotection in Parkinson's disease. [PDF]

Front Pharmacol
Arias-Carrión O, Guerra-Crespo M, Soto-Rojas LO, Valle Y, Ortega-Robles E, Ortuño-Sahagún D.   +5 more
europepmc   +1 more source